Global Biosurgery Market Size Study & Forecast, by Product (Surgical Sealants, Hemostatic Agents, Adhesion Barriers, Soft Tissue Attachments) and Application (General Surgery, Orthopedic Surgery) and Regional Forecasts 2025-2035

Description

The Global Biosurgery Market, valued at approximately USD 26.9 billion in 2024, is set to expand at a robust CAGR of 4.70% from 2025 to 2035. Biosurgery encompasses a sophisticated portfolio of advanced medical products designed to minimize intraoperative and postoperative complications, promote natural healing processes, and enhance surgical outcomes. These solutions, ranging from surgical sealants and hemostatic agents to adhesion barriers and soft tissue attachments, have become indispensable in modern operating rooms, addressing complex surgical needs in both routine and high-risk procedures. The market growth is being driven by a surge in surgical volumes worldwide, owing to an aging population, an increase in trauma and sports injuries, and the rising prevalence of chronic conditions that necessitate surgical intervention. Additionally, innovations in biomaterials, bioresorbable polymers, and tissue engineering have significantly broadened the scope and efficacy of biosurgical products, paving the way for higher adoption rates across multiple specialties.

Increasingly, hospitals and surgical centers are recognizing the clinical and economic benefits of integrating biosurgery products into standard protocols. For instance, the ability of hemostatic agents to reduce operative bleeding not only improves patient safety but also shortens recovery times and reduces overall treatment costs. The same applies to surgical sealants and adhesion barriers, which minimize postoperative complications and lower the likelihood of reoperation. This growing awareness, coupled with favorable reimbursement policies in key healthcare markets, is accelerating demand. Moreover, rising investments in research aimed at developing next-generation biosurgery solutions with enhanced biocompatibility, stronger mechanical performance, and faster resorption profiles are likely to further bolster market expansion over the forecast horizon.

Regionally, North America dominated the market in 2024, supported by its advanced healthcare infrastructure, high surgical procedure volumes, and strong presence of leading medical device manufacturers. The United States, in particular, benefits from rapid technology adoption and a well-established reimbursement framework that incentivizes the use of advanced biosurgical products. Europe follows closely, driven by growing demand for minimally invasive surgeries, an increasing elderly population, and stringent regulatory frameworks that encourage high-quality product development. Meanwhile, the Asia Pacific region is projected to record the fastest growth from 2025 to 2035, fueled by expanding healthcare access, rising medical tourism, and government-led initiatives to modernize surgical facilities in countries such as China, India, and South Korea. Emerging markets in Latin America and the Middle East & Africa are also showing promising potential, as infrastructure development and training programs gradually increase the availability and adoption of advanced biosurgical techniques.

Major market player included in this report are:

Johnson & Johnson (Ethicon)
Medtronic plc
Baxter International Inc.
Becton, Dickinson and Company (BD)
Stryker Corporation
Integra LifeSciences Holdings Corporation
CSL Limited
CryoLife, Inc.
Hemostasis LLC
Sanofi S.A.
B. Braun Melsungen AG
Smith & Nephew plc
Takeda Pharmaceutical Company Limited
Zimmer Biomet Holdings, Inc.
Pfizer Inc.

Global Biosurgery Market Report Scope:

Historical Data - 2023, 2024
Base Year for Estimation - 2024
Forecast period - 2025-2035
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent up to 8 analysts' working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study. The report also provides detailed information about crucial aspects, such as driving factors and challenges, which will define the future growth of the market. Additionally, it incorporates potential opportunities in micro-markets for stakeholders to invest, along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segments of the market are explained below:

By Product:

Surgical Sealants
Hemostatic Agents
Adhesion Barriers
Soft Tissue Attachments

By Application:

General Surgery
Orthopedic Surgery

By Region:

North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
UAE
Saudi Arabia
South Africa
Rest of Middle East & Africa

Key Takeaways:

Market Estimates & Forecast for 10 years from 2025 to 2035.
Annualized revenues and regional level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market.

Chapter 1. Global Biosurgery Market Report Scope & Methodology

1.1. Research Objective
1.2. Research Methodology
- 1.2.1. Forecast Model
- 1.2.2. Desk Research
- 1.2.3. Top Down and Bottom-Up Approach
1.3. Research Attributes
1.4. Scope of the Study
- 1.4.1. Market Definition
- 1.4.2. Market Segmentation
1.5. Research Assumption
- 1.5.1. Inclusion & Exclusion
- 1.5.2. Limitations
- 1.5.3. Years Considered for the Study

Chapter 2. Executive Summary

2.1. CEO/CXO Standpoint
2.2. Strategic Insights
2.3. ESG Analysis
2.4. key Findings

Chapter 3. Global Biosurgery Market Forces Analysis

3.1. Market Forces Shaping The Global Biosurgery Market (2024-2035)
3.2. Drivers
- 3.2.1. Rising surgical volumes driven by aging demographics and chronic disease burden
- 3.2.2. Advances in biomaterials (bioresorbables, tissue engineering) and favorable reimbursement
3.3. Restraints
- 3.3.1. High product costs and budget constraints in low-resource settings
- 3.3.2. Stringent regulatory pathways and risks of product recalls/adverse events
3.4. Opportunities
- 3.4.1. Accelerating adoption of minimally invasive & outpatient procedures across APAC and MEA
- 3.4.2. Next-generation combination products and integration with digital/robotic surgery ecosystems

Chapter 4. Global Biosurgery Industry Analysis

4.1. Porter's 5 Forces Model
- 4.1.1. Bargaining Power of Buyer
- 4.1.2. Bargaining Power of Supplier
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
4.2. Porter's 5 Force Forecast Model (2024-2035)
4.3. PESTEL Analysis
- 4.3.1. Political
- 4.3.2. Economical
- 4.3.3. Social
- 4.3.4. Technological
- 4.3.5. Environmental
- 4.3.6. Legal
4.4. Top Investment Opportunities
4.5. Top Winning Strategies (2025)
4.6. Market Share Analysis (2024-2025)
4.7. Global Pricing Analysis And Trends 2025
4.8. Analyst Recommendation & Conclusion

Chapter 5. Global Biosurgery Market Size & Forecasts by Product 2025-2035

5.1. Market Overview
5.2. Global Biosurgery Market Performance - Potential Analysis (2025)
5.3. Surgical Sealants
- 5.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.3.2. Market size analysis, by region, 2025-2035
5.4. Hemostatic Agents
- 5.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.4.2. Market size analysis, by region, 2025-2035
5.5. Adhesion Barriers
- 5.5.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.5.2. Market size analysis, by region, 2025-2035
5.6. Soft Tissue Attachments
- 5.6.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.6.2. Market size analysis, by region, 2025-2035

Chapter 6. Global Biosurgery Market Size & Forecasts by Application 2025-2035

6.1. Market Overview
6.2. Global Biosurgery Market Performance - Potential Analysis (2025)
6.3. General Surgery
- 6.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.3.2. Market size analysis, by region, 2025-2035
6.4. Orthopedic Surgery
- 6.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.4.2. Market size analysis, by region, 2025-2035

Chapter 7. Global Biosurgery Market Size & Forecasts by Region 2025-2035

7.1. Biosurgery Market, Regional Market Snapshot
7.2. Top Leading & Emerging Countries
7.3. North America Biosurgery Market
- 7.3.1. U.S. Biosurgery Market
  - 7.3.1.1. Product breakdown size & forecasts, 2025-2035
  - 7.3.1.2. Application breakdown size & forecasts, 2025-2035
- 7.3.2. Canada Biosurgery Market
  - 7.3.2.1. Product breakdown size & forecasts, 2025-2035
  - 7.3.2.2. Application breakdown size & forecasts, 2025-2035
7.4. Europe Biosurgery Market
- 7.4.1. UK Biosurgery Market
  - 7.4.1.1. Product breakdown size & forecasts, 2025-2035
  - 7.4.1.2. Application breakdown size & forecasts, 2025-2035
- 7.4.2. Germany Biosurgery Market
  - 7.4.2.1. Product breakdown size & forecasts, 2025-2035
  - 7.4.2.2. Application breakdown size & forecasts, 2025-2035
- 7.4.3. France Biosurgery Market
  - 7.4.3.1. Product breakdown size & forecasts, 2025-2035
  - 7.4.3.2. Application breakdown size & forecasts, 2025-2035
- 7.4.4. Spain Biosurgery Market
  - 7.4.4.1. Product breakdown size & forecasts, 2025-2035
  - 7.4.4.2. Application breakdown size & forecasts, 2025-2035
- 7.4.5. Italy Biosurgery Market
  - 7.4.5.1. Product breakdown size & forecasts, 2025-2035
  - 7.4.5.2. Application breakdown size & forecasts, 2025-2035
- 7.4.6. Rest of Europe Biosurgery Market
  - 7.4.6.1. Product breakdown size & forecasts, 2025-2035
  - 7.4.6.2. Application breakdown size & forecasts, 2025-2035
7.5. Asia Pacific Biosurgery Market
- 7.5.1. China Biosurgery Market
  - 7.5.1.1. Product breakdown size & forecasts, 2025-2035
  - 7.5.1.2. Application breakdown size & forecasts, 2025-2035
- 7.5.2. India Biosurgery Market
  - 7.5.2.1. Product breakdown size & forecasts, 2025-2035
  - 7.5.2.2. Application breakdown size & forecasts, 2025-2035
- 7.5.3. Japan Biosurgery Market
  - 7.5.3.1. Product breakdown size & forecasts, 2025-2035
  - 7.5.3.2. Application breakdown size & forecasts, 2025-2035
- 7.5.4. Australia Biosurgery Market
  - 7.5.4.1. Product breakdown size & forecasts, 2025-2035
  - 7.5.4.2. Application breakdown size & forecasts, 2025-2035
- 7.5.5. South Korea Biosurgery Market
  - 7.5.5.1. Product breakdown size & forecasts, 2025-2035
  - 7.5.5.2. Application breakdown size & forecasts, 2025-2035
- 7.5.6. Rest of APAC Biosurgery Market
  - 7.5.6.1. Product breakdown size & forecasts, 2025-2035
  - 7.5.6.2. Application breakdown size & forecasts, 2025-2035
7.6. Latin America Biosurgery Market
- 7.6.1. Brazil Biosurgery Market
  - 7.6.1.1. Product breakdown size & forecasts, 2025-2035
  - 7.6.1.2. Application breakdown size & forecasts, 2025-2035
- 7.6.2. Mexico Biosurgery Market
  - 7.6.2.1. Product breakdown size & forecasts, 2025-2035
  - 7.6.2.2. Application breakdown size & forecasts, 2025-2035
7.7. Middle East and Africa Biosurgery Market
- 7.7.1. UAE Biosurgery Market
  - 7.7.1.1. Product breakdown size & forecasts, 2025-2035
  - 7.7.1.2. Application breakdown size & forecasts, 2025-2035
- 7.7.2. Saudi Arabia (KSA) Biosurgery Market
  - 7.7.2.1. Product breakdown size & forecasts, 2025-2035
  - 7.7.2.2. Application breakdown size & forecasts, 2025-2035
- 7.7.3. South Africa Biosurgery Market
  - 7.7.3.1. Product breakdown size & forecasts, 2025-2035
  - 7.7.3.2. Application breakdown size & forecasts, 2025-2035

Chapter 8. Competitive Intelligence

8.1. Top Market Strategies
8.2. Johnson & Johnson (Ethicon)
- 8.2.1. Company Overview
- 8.2.2. Key Executives
- 8.2.3. Company Snapshot
- 8.2.4. Financial Performance (Subject to Data Availability)
- 8.2.5. Product/Services Port
- 8.2.6. Recent Development
- 8.2.7. Market Strategies
- 8.2.8. SWOT Analysis
8.3. Medtronic plc
8.4. Baxter International Inc.
8.5. Becton, Dickinson and Company (BD)
8.6. Stryker Corporation
8.7. Integra LifeSciences Holdings Corporation
8.8. CSL Limited
8.9. CryoLife, Inc.
8.10. Hemostasis LLC
8.11. Sanofi S.A.
8.12. B. Braun Melsungen AG
8.13. Smith & Nephew plc
8.14. Takeda Pharmaceutical Company Limited
8.15. Zimmer Biomet Holdings, Inc.
8.16. Pfizer Inc.